ID EM-3 AC CVCL_2033 SY EM3 DR BTO; BTO_0005905 DR CLO; CLO_0002923 DR CLDB; cl1165 DR Cell_Model_Passport; SIDM01046 DR Cosmic; 787492 DR Cosmic; 798662 DR Cosmic; 994179 DR Cosmic; 1026571 DR DSMZ; ACC-134 DR DSMZCellDive; ACC-134 DR Wikidata; Q54832265 RX CelloPub=CLPUB00038; RX DOI=10.1016/B978-0-12-221970-2.50457-5; RX PubMed=3030532; RX PubMed=3332852; RX PubMed=3856862; RX PubMed=10071072; RX PubMed=10576511; RX PubMed=10637496; RX PubMed=15843827; RX PubMed=25877200; CC Population: Caucasian. CC Doubling time: 2 days (CelloPub=CLPUB00038); ~40 hours (DSMZ=ACC-134). CC Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=10071072; PubMed=10576511; PubMed=15843827). CC Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371. ST Source(s): DSMZ=ACC-134; PubMed=25877200 ST Amelogenin: X ST CSF1PO: 10,12 ST D13S317: 9,12 ST D16S539: 11,12 ST D18S51: 13 ST D19S433: 15,16 ST D21S11: 30 ST D2S1338: 22,24 ST D3S1358: 14,16 ST D5S818: 8,12 ST D7S820: 10 ST D8S1179: 14 ST FGA: 21,22 ST Penta D: 13,14 ST Penta E: 7,16 ST TH01: 9.3 ST TPOX: 8,12 ST vWA: 14,17 DI NCIt; C7320; Childhood chronic myelogenous leukemia, BCR-ABL1 positive DI ORDO; Orphanet_521; Chronic myeloid leukemia OX NCBI_TaxID=9606; ! Homo sapiens (Human) OI CVCL_1196 ! EM-2 SX Female AG 5Y CA Cancer cell line DT Created: 04-04-12; Last updated: 19-12-24; Version: 24 // RX PubMed=10576511; DOI=10.1016/S0145-2126(99)00131-9; RA Uphoff, Cord C. RA Habig, Silke RA Fombonne, Severine RA Matsuo, Yoshinobu RA Drexler, Hans Gunther RT "ABL-BCR expression in BCR-ABL-positive human leukemia cell lines."; RL Leuk. Res. 23:1055-1060(1999). // RX PubMed=25877200; DOI=10.1038/nature14397; RA Yu, Ma-Mie RA Selvaraj, Suresh K. RA Liang-Chu, May M.Y. RA Aghajani, Sahar RA Busse, Matthew RA Yuan, Jean RA Lee, Genee RA Peale, Franklin V. RA Klijn, Christiaan RA Bourgon, Richard RA Kaminker, Joshua S. RA Neve, Richard M. RT "A resource for cell line authentication, annotation and quality RT control."; RL Nature 520:307-311(2015). // RX PubMed=15843827; DOI=10.1038/sj.leu.2403749; RA Hagstrom-Andersson, Anna K. RA Eden, Patrik RA Lindgren, David RA Nilsson, Jens RA Lassen, Carin RA Heldrup, Jesper RA Fontes, Magnus RA Borg, Ake RA Mitelman, Felix RA Johansson, Bertil RA Hoglund, Mattias RA Fioretos, Thoas RT "Gene expression profiling of leukemic cell lines reveals conserved RT molecular signatures among subtypes with specific genetic RT aberrations."; RL Leukemia 19:1042-1050(2005). // RX PubMed=3030532; DOI=10.1016/0165-4608(87)90188-9; RA Raskind, Wendy Herlihy RA Disteche, Christine M. RA Keating, Armand RA Singer, Jack W. RT "Correlation between cytogenetic and molecular findings in human RT chronic myelogenous leukemia lines EM-2 and EM-3."; RL Cancer Genet. Cytogenet. 25:271-284(1987). // RX PubMed=3856862; DOI=10.1073/pnas.82.6.1810; PMCID=PMC397362; RA Konopka, James B. RA Watanabe, Susan M. RA Singer, Jack W. RA Collins, Steven J. RA Witte, Owen Neil RT "Cell lines and clinical isolates derived from Ph1-positive chronic RT myelogenous leukemia patients express c-abl proteins with a common RT structural alteration."; RL Proc. Natl. Acad. Sci. U.S.A. 82:1810-1814(1985). // RX DOI=10.1016/B978-0-12-221970-2.50457-5; RA Drexler, Hans Gunther RT "The leukemia-lymphoma cell line factsbook."; RL (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001). // RX PubMed=10071072; DOI=10.1016/S0145-2126(98)00171-4; RA Drexler, Hans Gunther RA MacLeod, Roderick A.F. RA Uphoff, Cord C. RT "Leukemia cell lines: in vitro models for the study of Philadelphia RT chromosome-positive leukemia."; RL Leuk. Res. 23:207-215(1999). // RX PubMed=10637496; DOI=10.1038/sj.leu.2401604; RA Drexler, Hans Gunther RA Fombonne, Severine RA Matsuo, Yoshinobu RA Hu, Zhen-Bo RA Hamaguchi, Hiroyuki RA Uphoff, Cord C. RT "p53 alterations in human leukemia-lymphoma cell lines: in RT vitro artifact or prerequisite for cell immortalization?"; RL Leukemia 14:198-206(2000). // RX CelloPub=CLPUB00038; RA Keating, Armand RA Martin, Paul Joseph RA Bernstein, Irwin David RA Papayannopoulou, Thalia RA Raskind, Wendy Herlihy RA Singer, Jack W. RT "EM-2 and EM-3: two new Ph1+ myeloid cell lines."; RL (In book chapter) Normal and neoplastic hematopoiesis, UCLA symposia on molecular and cellular biology, New Series Vol. 9; Golde, David W. & Marks, Paul Alan (eds.); pp.513-520; Alan R. Liss; New York; USA (1983). // RX PubMed=3332852; DOI=10.1016/S0950-3536(87)80037-9; RA Keating, Armand RT "Ph positive CML cell lines."; RL Baillieres Clin. Haematol. 1:1021-1029(1987). //